The report Synthetic Biology Market focuses on major leading Market players, Key market segments and sub-segments to provide comprehensive and insightful data
The Global Synthetic Biology Market, which reached nearly $3.9 billion in 2016, should total $11.4 billion by 2021, growing at a five-year compound annual growth rate (CAGR) of 24.0% through 2021. Enabled products, the largest segment, should reach over $8.3 billion in 2021, up from $2.8 billion in 2016, demonstrating a five-year CAGR of 24.4%.
Core products, which reached $311.5 million in 2016, should grow to $1.1 billion in 2021 at a five-year CAGR of 30.0%.
Browse details of 266 pages research report on Global Synthetic Biology Market @ www.researchcosmos.com/reports/glo…nities/1861918236
Continuing advances in enabling technologies such as DNA synthesis and sequencing, specialty media, genome editing and bioinformatics, as well as a need for more efficient microbial production processes, are driving growth in the synthetic-biology global market.
Research Cosmos reveals in its new report that developments in these multidisciplinary fields promise to advance the synthetic-biology industry and create unique market opportunities.
The synthetic-biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products drive the development of the synthetic-biology industry.
Core products and technologies—standardized DNA parts, synthetic genes and chassis organisms—are the key tools by which cellular factories and systems produce enabled products.
Synthetic biology has established itself as an important discipline within the life sciences industry. While it has enormous potential for future applications, synthetic biology faces significant near-term commercial opportunities.
And, the list of new products and applications is growing. Applications include specialty chemicals, enzymes, synthetic genes and cells, as well as pharmaceuticals, agricultural seeds, vaccines, biofuels and chassis microorganisms.
Enabled products, the largest segment of the market, are expected to achieve high growth, including in the fields of drugs, vaccines, bio-based chemicals, genome-edited crops and renewable fuels. A trend toward higher-value specialty products, such as performance chemicals, flavors and fragrances, drug/therapies and novel crop traits, are driving growth in this segment.
Avail Sample Market Brochure of the report for more information, Get a Copy @ www.researchcosmos.com/request/1861918236
Core products, which owns the highest five-year CAGR (30.0%) among segments, is growing due to increased demand for synthetic genes, the rise of synthetic-biology foundries and efforts by organizations including the BioBricks Foundation, DIYbio and SynBERC to develop and apply DNA constructs. Enabling technologies as a segment continues to innovate, for example in the fields of gene synthesis and genome editing.
Innovations in enabling technologies support the development of core products and enabled products
"New genome-editing technologies, including cluttered regularly interspaced short palindromic repeats (CRISPR) and transcription activator-like effector nuclease (TALEN) systems, are significantly impacting the industry,” says Research Cosmos.
"The agriculture industry is projected as a high user of synthetic-biology products. In particular, genome editing is forecast to become a key tool for creating novel seeds due to its ease of use and non-GMO designation by regulatory authorities."
Synthetic Biology: Global Markets characterizes and quantifies the synthetic-biology-product market potential by product type and end-use market segments. The report also examines market applications, industry structure, competitive dynamics, and key strategic alliances and acquisitions.
Global market drivers and trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021 also are provided.
Make an Inquiry @ www.researchcosmos.com/inquire/1861918236
The study scope includes core synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, genome editing, bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years.
We analyze key synthetic-biology technologies and products to determine present and future market status, and forecasted growth from 2016 through 2021. We also discuss strategic alliances, industry structures, competitive dynamics, patents and market driving forces.
- An overview of the global markets for synthetic biology.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells
- Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics
- Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture
- Analysis of the synthetic biology industry structure, competitors and intellectual property landscape
- An assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
- Profiles of major players in the industry
Request Report @ www.researchcosmos.com/customization/1861918236
For more information:Make an Inquiry about this report HERE!